Tavneos
Drug
Amgen Inc.
Total Payments
$2.4M
Transactions
8,072
Doctors
3,698
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $2.4M | 8,072 | 3,698 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.2M | 59 | 52.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $437,452 | 271 | 18.5% |
| Honoraria | $194,175 | 110 | 8.2% |
| Consulting Fee | $186,338 | 67 | 7.9% |
| Food and Beverage | $176,070 | 6,269 | 7.5% |
| Travel and Lodging | $59,181 | 195 | 2.5% |
| Education | $35,431 | 1,097 | 1.5% |
| Grant | $17,500 | 2 | 0.7% |
| Space rental or facility fees (teaching hospital only) | $6,000 | 2 | 0.3% |
Payments by Type
Research
$1.2M
59 transactions
General
$1.1M
8,013 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CL020_168 | Amgen Inc. | $1.1M | 0 |
| Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa | Amgen Inc. | $102,469 | 0 |
Top Doctors Receiving Payments for Tavneos
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Phila, PA | $1.3M | 63 |
| , DO | Rheumatology | Cleveland, OH | $72,153 | 73 |
| , MD | Internal Medicine | Colleyville, TX | $58,472 | 98 |
| , MD | Nephrology | Palo Alto, CA | $55,898 | 75 |
| , M.D | Infectious Disease | New York, NY | $46,534 | 8 |
| Martin Okun | Dermatology | Fort Atkinson, WI | $36,500 | 7 |
| , DO | Rheumatology | Austin, TX | $30,238 | 50 |
| , M.D | Internal Medicine | Cleveland, OH | $25,312 | 21 |
| , M.D | Rheumatology | Portola Valley, CA | $23,385 | 13 |
| , M.D | Specialist | San Diego, CA | $22,894 | 31 |
| , MD | Internal Medicine | Albany, NY | $21,076 | 19 |
| , MD | Nephrology | Orlando, FL | $19,355 | 24 |
| , MD | Internal Medicine | Carmel, IN | $18,397 | 21 |
| , M.D | Internal Medicine | Boston, MA | $17,585 | 13 |
| , MD | Nephrology | San Bernardino, CA | $16,715 | 17 |
| , DO | Rheumatology | Peoria, AZ | $16,122 | 17 |
| , MD | Rheumatology | Bolivar, MO | $15,751 | 18 |
| , M.D | Nephrology | Cleveland, OH | $15,593 | 16 |
| , MD | Rheumatology | Charlotte, NC | $15,551 | 18 |
| , MD, MPH | Rheumatology | Philadelphia, PA | $13,800 | 5 |
| , M.D., PH.D | Internal Medicine | Chapel Hill, NC | $13,372 | 12 |
| , M.D | Nephrology | Fort Lauderdale, FL | $13,320 | 19 |
| , M.D | Rheumatology | Beverly Hills, CA | $13,004 | 10 |
| , MD | Internal Medicine | Chicago, IL | $12,640 | 8 |
| , M.D | Pulmonary Disease | Rochester, MN | $11,875 | 7 |
Ad
Manufacturing Companies
- Amgen Inc. $2.4M
Product Information
- Type Drug
- Total Payments $2.4M
- Total Doctors 3,698
- Transactions 8,072
About Tavneos
Tavneos is a drug associated with $2.4M in payments to 3,698 healthcare providers, recorded across 8,072 transactions in the CMS Open Payments database. The primary manufacturer is Amgen Inc..
Payment data is available from 2022 to 2022. In 2022, $2.4M was paid across 8,072 transactions to 3,698 doctors.
The most common payment nature for Tavneos is "Unspecified" ($1.2M, 52.9% of total).
Tavneos is associated with 2 research studies, including "CL020_168" ($1.1M).